UAE authorities have issued an urgent recall of two insecticide products marketed under the Goodbye All Insects brand after identifying multiple regulatory and safety concerns, including the presence of a prohibited substance in one of the products
The action was announced by the Emirates Drug Establishment (EDE), which said the recall forms part of its ongoing efforts to protect consumers and ensure that products available in the UAE market meet approved health, safety and regulatory standards.
The products affected by the recall are Goodbye All Insects Max Kills in One Spray and Goodbye All Insects Spray, both manufactured by SCITRA.
According to the EDE, investigations uncovered regulatory and technical violations linked to the sale and distribution of products that had not been officially registered with the authority. Registration is a key requirement designed to ensure that products undergo the necessary evaluation before reaching consumers.
Product does not comply with specifications
In addition to the registration issues, the authority found discrepancies in the concentration levels of active ingredients in one of the insecticides. Officials said the product did not comply with approved specifications or relevant international standards, raising concerns about quality and consistency.
More significantly, one of the recalled products was found to contain a prohibited substance. As a result, authorities ordered its immediate removal from the market to prevent further distribution and reduce any potential risk to public health.
The Emirates Drug Establishment said it is working closely with regulatory agencies and relevant authorities across the UAE to ensure the affected products are removed from retail stores, distribution channels and online marketplaces in accordance with established regulatory procedures.
Consumers urged to stop using products
Consumers who have already purchased either product have been strongly advised to stop using them immediately. Authorities also urged the public not to buy, sell or distribute the recalled products and to follow official guidance issued by relevant government entities.
The Emirates Drug Establishment reaffirmed its commitment to transparency, proactive risk management and rapid response measures when potential safety concerns are identified. Officials added that cooperation with local regulatory partners remains a key part of efforts to safeguard public health and ensure only safe, compliant products remain available in the UAE market.
Residents are encouraged to stay informed through official announcements and report any concerns regarding recalled or non-compliant products to the relevant authorities.